Centene Raises 2026 Earnings Guidance Following Strong Q3 Performance
Centene (CNC) reported third-quarter 2026 adjusted diluted earnings per share of $0.58, outperforming expectations due to stabilizing medical costs and disciplined administrative spending. The company raised its full-year 2026 adjusted earnings per share guidance to above $5.20, driven by operational improvements across its core health plan segments. A significant highlight is the Medicare Advantage segment reaching a breakeven forecast in 2026, one year ahead of previous projections. Additionally, the Commercial Individual Marketplace achieved pre-tax margins at the top end of its target range (5.0%), while management continues to negotiate with state agencies to ensure Medicaid reimbursement rates align with rising healthcare costs.
Tickers: $CNC
Topics: earnings report guidance increase Medicare Advantage profit margins
Read the full article at Motley Fool
Part of the story Moderna Upgrades 2026 Revenue Guidance Following Positive Phase 3 Cancer Vaccine Results (4 articles)